Christine Mavros

2.1k total citations · 1 hit paper
6 papers, 1.7k citations indexed

About

Christine Mavros is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Christine Mavros has authored 6 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 3 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in Christine Mavros's work include Alzheimer's disease research and treatments (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Amino Acid Enzymes and Metabolism (1 paper). Christine Mavros is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Amino Acid Enzymes and Metabolism (1 paper). Christine Mavros collaborates with scholars based in Australia, United States and Sweden. Christine Mavros's co-authors include Ashley I. Bush, Robert A. Cherny, Colin L. Masters, Rudolph E. Tanzi, Konrad Beyreuther, Darryl Carrington, Irene Volitakis, Qiao‐Xin Li, Steve Macfarlane and Stephen N. Davis and has published in prestigious journals such as The Lancet, PLoS ONE and The FASEB Journal.

In The Last Decade

Christine Mavros

6 papers receiving 1.7k citations

Hit Papers

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clio... 2003 2026 2010 2018 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Mavros Australia 6 1.1k 540 462 323 196 6 1.7k
Darryl Carrington Australia 5 1.0k 1.0× 366 0.7× 512 1.1× 340 1.1× 248 1.3× 7 1.4k
Keyla Perez Australia 21 1.5k 1.4× 789 1.5× 394 0.9× 319 1.0× 304 1.6× 40 2.1k
Fedá E. Ali Australia 12 1.1k 1.0× 512 0.9× 329 0.7× 223 0.7× 172 0.9× 15 1.5k
Katrina Laughton Australia 19 1.2k 1.1× 478 0.9× 621 1.3× 201 0.6× 103 0.5× 22 2.0k
Konrad Beyreuther Germany 17 1.0k 1.0× 707 1.3× 246 0.5× 303 0.9× 119 0.6× 18 1.5k
Marc d. Paradis United States 8 1.4k 1.3× 722 1.3× 735 1.6× 270 0.8× 225 1.1× 10 2.1k
David Bonda United States 21 915 0.9× 780 1.4× 203 0.4× 306 0.9× 118 0.6× 37 2.1k
Adam P. Gunn Australia 12 643 0.6× 275 0.5× 310 0.7× 212 0.7× 156 0.8× 19 1.1k
Clémence Cheignon France 10 1.0k 1.0× 645 1.2× 243 0.5× 465 1.4× 241 1.2× 15 2.0k
Andrea Schlicksupp Germany 15 645 0.6× 592 1.1× 421 0.9× 159 0.5× 80 0.4× 20 1.4k

Countries citing papers authored by Christine Mavros

Since Specialization
Citations

This map shows the geographic impact of Christine Mavros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Mavros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Mavros more than expected).

Fields of papers citing papers by Christine Mavros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Mavros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Mavros. The network helps show where Christine Mavros may publish in the future.

Co-authorship network of co-authors of Christine Mavros

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Mavros. A scholar is included among the top collaborators of Christine Mavros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Mavros. Christine Mavros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Dean, Olivia, Maarten van den Buuse, Michael Berk, et al.. (2011). N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder. Neuroscience Letters. 499(3). 149–153. 64 indexed citations
2.
Melov, Simon, Paul A. Adlard, Karl Morten, et al.. (2007). Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau. PLoS ONE. 2(6). e536–e536. 290 indexed citations
3.
Ali, Fedá E., Robert A. Cherny, Christine Mavros, et al.. (2005). Dimerisation of N -acetyl- l -tyrosine ethyl ester and Aβ peptides via formation of dityrosine. Free Radical Research. 40(1). 1–9. 22 indexed citations
4.
Barnham, Kevin J., Fredrik Hæffner, Giuseppe D. Ciccotosto, et al.. (2004). Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid. The FASEB Journal. 18(12). 1427–1429. 230 indexed citations
5.
Ritchie, Craig, Ashley I. Bush, Andrew Mackinnon, et al.. (2003). Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease. Archives of Neurology. 60(12). 1685–1685. 810 indexed citations breakdown →
6.
Goldstein, Lee E., Julien Muffat, Robert A. Cherny, et al.. (2003). Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. The Lancet. 361(9365). 1258–1265. 281 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026